Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia.

Ogier N, Amiot MJ, Georgé S, Maillot M, Mallmann C, Maraninchi M, Morange S, Lescuyer JF, Peltier SL, Cardinault N.

Eur J Nutr. 2013 Mar;52(2):547-57. doi: 10.1007/s00394-012-0357-x. Epub 2012 Apr 24.

PMID:
22527287
2.

Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study.

Barrat E, Zaïr Y, Sirvent P, Chauveau P, Maudet C, Housez B, Derbord E, Lescuyer JF, Bard JM, Cazaubiel M, Peltier SL.

Eur J Nutr. 2013 Dec;52(8):1843-52. doi: 10.1007/s00394-012-0486-2. Epub 2012 Dec 25.

PMID:
23266743
3.

A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.

Barrat E, Zaïr Y, Ogier N, Housez B, Vergara C, Maudet C, Lescuyer JF, Bard JM, Carpentier YA, Cazaubiel M, Peltier SL.

Int J Food Sci Nutr. 2013 Nov;64(7):882-9. doi: 10.3109/09637486.2013.809405. Epub 2013 Jul 2.

PMID:
23815518
4.
5.

Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial.

Rondanelli M, Giacosa A, Opizzi A, Faliva MA, Sala P, Perna S, Riva A, Morazzoni P, Bombardelli E.

Int J Food Sci Nutr. 2013 Feb;64(1):7-15. doi: 10.3109/09637486.2012.700920. Epub 2012 Jun 29.

PMID:
22746542
6.

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.

Ballantyne CM, Pazzucconi F, Pintó X, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT.

Clin Ther. 2001 Feb;23(2):177-92.

PMID:
11293552
7.

Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia.

Maki KC, Lawless AL, Reeves MS, Kelley KM, Dicklin MR, Jenks BH, Shneyvas E, Brooks JR.

Nutrition. 2013 Jan;29(1):96-100. doi: 10.1016/j.nut.2012.05.002. Epub 2012 Jul 15.

8.

Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.

Ose L, Davidson MH, Stein EA, Kastelein JJ, Scott RS, Hunninghake DB, Campodonico S, Insull W, Escobar ID, Schrott HG, Stepanavage ME, Wu M, Tate AC, Melino MR, Mercuri M, Mitchel YB.

Clin Cardiol. 2000 Jan;23(1):39-46.

9.

Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.

Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.

Drugs R D. 2005;6(4):207-19.

PMID:
16050054
10.

Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial.

Olsson AG, Pauciullo P, Soska V, Luley C, Pieters RE, Broda G, Palacios B; Fluvastatin Study Group..

Clin Ther. 2001 Jan;23(1):45-61.

PMID:
11219479
11.

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement.

Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL.

Am J Clin Nutr. 1999 Feb;69(2):231-6.

12.

Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial.

Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J.

Arch Intern Med. 2003 Jun 23;163(12):1448-53.

PMID:
12824094
13.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
14.

Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study.

Nohr LA, Rasmussen LB, Straand J.

Complement Ther Med. 2009 Jan;17(1):16-22. doi: 10.1016/j.ctim.2008.07.001. Epub 2008 Aug 15.

PMID:
19114224
15.

Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols.

Korpela R, Tuomilehto J, Högström P, Seppo L, Piironen V, Salo-Väänänen P, Toivo J, Lamberg-Allardt C, Kärkkäinen M, Outila T, Sundvall J, Vilkkilä S, Tikkanen MJ.

Eur J Clin Nutr. 2006 May;60(5):633-42.

PMID:
16404415
16.

Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.

Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.

Int J Clin Pharmacol Res. 2001;21(1):43-57.

PMID:
11708574
17.

Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.

Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.

Am Heart J. 2006 Nov;152(5):982.e1-5.

PMID:
17070175
18.

Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.

Francini-Pesenti F, Beltramolli D, Dall'acqua S, Brocadello F.

Phytother Res. 2008 Mar;22(3):318-22. doi: 10.1002/ptr.2315.

PMID:
18167048
19.

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.

Lewis JH, Mortensen ME, Zweig S, Fusco MJ, Medoff JR, Belder R; Pravastatin in Chronic Liver Disease Study Investigators..

Hepatology. 2007 Nov;46(5):1453-63.

PMID:
17668878
20.

Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia.

Dujovne CA, Ettinger MP, McNeer JF, Lipka LJ, LeBeaut AP, Suresh R, Yang B, Veltri EP; Ezetimibe Study Group..

Am J Cardiol. 2002 Nov 15;90(10):1092-7. Erratum in: Am J Cardiol. 2003 Jun 1;91(11):1399.

PMID:
12423709

Supplemental Content

Support Center